These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 26312564)

  • 1. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
    Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
    Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion.
    Geng W; Liang W; Fan Y; Ye Z; Zhang L
    Mol Med Rep; 2018 Jan; 17(1):465-473. PubMed ID: 29115580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
    Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W
    Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
    Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
    Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role for drebrin in regulating progranulin bioactivity in bladder cancer.
    Xu SQ; Buraschi S; Morcavallo A; Genua M; Shirao T; Peiper SC; Gomella LG; Birbe R; Belfiore A; Iozzo RV; Morrione A
    Oncotarget; 2015 May; 6(13):10825-39. PubMed ID: 25839164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
    Fan C; Liu J; Tian J; Zhang Y; Yan M; Zhu C
    Cytogenet Genome Res; 2018; 154(4):209-216. PubMed ID: 29902801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
    Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.
    Zhang Q; Zhuang J; Deng Y; Zhao X; Tang B; Yao D; Zhao W; Chang C; Lu Q; Chen W; Zhang S; Ji C; Cao L; Guo H
    Oncotarget; 2015 Oct; 6(31):32177-92. PubMed ID: 26375441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.
    Rao W; Li H; Song F; Zhang R; Yin Q; Wang Y; Xi Y; Ge H
    Carcinogenesis; 2014 Jul; 35(7):1573-81. PubMed ID: 24667688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.